Virology Journal

Papers
(The H4-Index of Virology Journal is 36. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
The effect of temperature on persistence of SARS-CoV-2 on common surfaces440
COVID-19 infection: an overview on cytokine storm and related interventions211
Rapid SARS-CoV-2 antigen detection assay in comparison with real-time RT-PCR assay for laboratory diagnosis of COVID-19 in Thailand205
False negative rate of COVID-19 PCR testing: a discordant testing analysis152
Characterization of accessory genes in coronavirus genomes123
COVID-19 infection among healthcare workers: a cross-sectional study in southwest Iran104
Evolutionary trajectory of SARS-CoV-2 and emerging variants103
Rapid point-of-care detection of SARS-CoV-2 using reverse transcription loop-mediated isothermal amplification (RT-LAMP)94
Influenza co-infection associated with severity and mortality in COVID-19 patients82
Favipiravir versus other antiviral or standard of care for COVID-19 treatment: a rapid systematic review and meta-analysis77
SARS-CoV-2: characteristics and current advances in research77
Impact of COVID-19 pandemic on the prevalence of respiratory viruses in children with lower respiratory tract infections in China74
Harnessing the immune system to overcome cytokine storm and reduce viral load in COVID-19: a review of the phases of illness and therapeutic agents69
Analysis of the efficacy of HIV protease inhibitors against SARS-CoV-2′s main protease69
Liver injury in COVID-19: clinical features and treatment management60
Replication kinetics and infectivity of SARS-CoV-2 variants of concern in common cell culture models59
The newly emerged COVID-19 disease: a systemic review59
The role of host eIF2α in viral infection59
Hepatitis E virus infection during pregnancy58
In vitro virucidal activity of Echinaforce®, an Echinacea purpurea preparation, against coronaviruses, including common cold coronavirus 229E and SARS-CoV-255
Specific cytokines in the inflammatory cytokine storm of patients with COVID-19-associated acute respiratory distress syndrome and extrapulmonary multiple-organ dysfunction54
Evaluation of SARS-CoV-2 neutralizing antibodies using a vesicular stomatitis virus possessing SARS-CoV-2 spike protein53
Intranasal exposure of African green monkeys to SARS-CoV-2 results in acute phase pneumonia with shedding and lung injury still present in the early convalescence phase51
COVID-19 pandemic: current knowledge about the role of pets and other animals in disease transmission51
Association of dyslipidemia with the severity and mortality of coronavirus disease 2019 (COVID-19): a meta-analysis50
Characterization of four virulent Klebsiella pneumoniae bacteriophages, and evaluation of their potential use in complex phage preparation43
Resource-efficient internally controlled in-house real-time PCR detection of SARS-CoV-241
The association between interferon lambda 3 and 4 gene single-nucleotide polymorphisms and the recovery of COVID-19 patients41
A new Hendra virus genotype found in Australian flying foxes40
Effectiveness of disinfectants against the spread of tobamoviruses: Tomato brown rugose fruit virus and Cucumber green mottle mosaic virus40
Pathophysiology of Post-COVID syndromes: a new perspective40
SARS-CoV-2 infection in pediatric population before and during the Delta (B.1.617.2) and Omicron (B.1.1.529) variants era40
Inhibitors of endosomal acidification suppress SARS-CoV-2 replication and relieve viral pneumonia in hACE2 transgenic mice39
Estimation of the basic reproduction number (R0) for the novel coronavirus disease in Sri Lanka38
Precision therapeutic targets for COVID-1937
Neutralization assay with SARS-CoV-1 and SARS-CoV-2 spike pseudotyped murine leukemia virions37
The SARS-CoV-2 nucleocapsid protein: its role in the viral life cycle, structure and functions, and use as a potential target in the development of vaccines and diagnostics36
0.036306858062744